ICD-10 Coding for Mediastinal Lymphadenopathy(C34.9, C34.9U, C38.0)
Comprehensive guide on ICD-10 coding for mediastinal lymphadenopathy, including documentation requirements and common pitfalls.
Complete code families applicable to Mediastinal Lymphadenopathy
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| R59.0 | Localized enlarged lymph nodes | Use when mediastinal lymphadenopathy is localized and no specific cause is identified. |
|
| C78.2 | Secondary malignant neoplasm of mediastinum | Use when mediastinal lymphadenopathy is due to metastasis. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutMediastinal Lymphadenopathy
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Mediastinal Lymphadenopathy.
Failing to document biopsy results
Impact
Clinical: Inaccurate diagnosis and treatment planning., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims.
Mitigation
Ensure biopsy results are included in the medical record., Cross-check documentation before submission.
Using R59.9 when mediastinal location is specified
Impact
Reimbursement: Incorrect DRG assignment leading to reimbursement issues., Compliance: Non-compliance with coding specificity requirements., Data Quality: Decreased accuracy in clinical data reporting.
Mitigation
Use R59.0 for localized mediastinal lymphadenopathy.
Incorrect sequencing of codes
Impact
Failure to sequence primary and secondary codes correctly.
Mitigation
Review coding guidelines for sequencing rules.